Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
1151
DELISTED
Amedisys
AMED
| $5.67M | 0.01% |
338,601
+193,921
| +134% | +$2.75M |
|
|
CUK
1152
DELISTED
Carnival PLC
CUK
| $5.63M | 0.01% |
148,300
+50,000
| +51% | +$1.97M |
|
1153
Exelixis
EXEL
$12.5B
| $5.62M | 0.01% |
+1,658,150
| New | +$5.73M |
|
|
TOWR
1154
DELISTED
Tower International, Inc.
TOWR
| $5.61M | 0.01% |
152,400
+35,954
| +31% | +$1.09M |
|
|
CAJ
1155
DELISTED
Canon, Inc.
CAJ
| $5.59M | 0.01% |
170,599
-183,201
| -52% | -$5.89M |
|
|
TEN
1156
Tsakos Energy Navigation Ltd
TEN
$1.23B
| $5.58M | 0.01% |
166,900
+71,300
| +75% | +$2.57M |
|
|
GRA
1157
DELISTED
W.R. Grace & Co.
GRA
| $5.58M | 0.01% |
59,000
+19,900
| +51% | +$1.88M |
|
1158
Fulton Financial
FULT
$4.69B
| $5.58M | 0.01% |
450,045
+198,779
| +79% | +$2.43M |
|
|
BEAT
1159
DELISTED
BioTelemetry, Inc.
BEAT
| $5.57M | 0.01% |
777,200
+61,400
| +9% | +$489K |
|
1160
Enviri
NVRI
$583M
| $5.57M | 0.01% |
209,100
-436,333
| -68% | -$11.2M |
|
1161
Comtech Telecommunications
CMTL
$52.1M
| $5.55M | 0.01% |
148,750
-49,786
| -25% | -$1.67M |
|
|
CFN
1162
DELISTED
CAREFUSION CORPORATION
CFN
| $5.54M | 0.01% |
+125,000
| New | +$5.17M |
|
1163
Coeur Mining
CDE
$19B
| $5.52M | 0.01% |
601,490
-156,300
| -21% | -$1.28M |
|
1164
Assurant
AIZ
$13.9B
| $5.52M | 0.01% |
+84,200
| New | +$5.63M |
|
1165
Vera Bradley
VRA
$96.7M
| $5.51M | 0.01% |
+252,100
| New | +$6.63M |
|
1166
Civeo
CVEO
$345M
| $5.5M | 0.01% |
+18,308
| New | +$5.48M |
|
|
LHO
1167
DELISTED
LaSalle Hotel Properties
LHO
| $5.5M | 0.01% |
155,800
-579,600
| -79% | -$19.3M |
|
1168
Goldgroup Mining Inc.
GORO
$211M
| $5.5M | 0.01% |
1,086,200
+302,600
| +39% | +$1.38M |
|
1169
Willis Lease Finance
WLFC
$1.21B
| $5.49M | 0.01% |
671,607
+160,155
| +31% | +$1.1M |
|
|
NSR
1170
DELISTED
Neustar Inc
NSR
| $5.49M | 0.01% |
210,900
+141,500
| +204% | +$3.85M |
|
|
HNP
1171
DELISTED
Huaneng Power Intl, Inc.
HNP
| $5.48M | 0.01% |
121,100
-4,712
| -4% | -$195K |
|
1172
Plexus
PLXS
$7.25B
| $5.46M | 0.01% |
126,093
+62,973
| +100% | +$2.63M |
|
|
EFC
1173
Ellington Financial
EFC
$1.76B
| $5.45M | 0.01% |
227,176
+99,525
| +78% | +$2.37M |
|
|
PCYC
1174
DELISTED
PHARMACYCLICS INC
PCYC
| $5.42M | 0.01% |
60,400
+12,700
| +27% | +$1.19M |
|
|
AAV
1175
DELISTED
Advantage Oil & Gas Ltd
AAV
| $5.41M | 0.01% |
805,469
+609,269
| +311% | +$3.71M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.